Results 281 to 290 of about 7,440,138 (398)

Drug industry weakens US bill about disclosure of gifts [PDF]

, 2008
Bob Burton
openalex   +1 more source

Novel CT radiomics models for the postoperative prediction of early recurrence of resectable pancreatic adenocarcinoma: A single‐center retrospective study in China

Journal of Applied Clinical Medical Physics, EarlyView.
Abstract Purpose To assess the predictive capability of CT radiomics features for early recurrence (ER) of pancreatic ductal adenocarcinoma (PDAC). Methods Postoperative PDAC patients were retrospectively selected, all of whom had undergone preoperative CT imaging and surgery. Both patients with resectable or borderline‐resectable pancreatic cancer met
Xinze Du, Yongsu Ma, Kexin Wang, Xiejian Zhong, Jianxin Wang, Xiaodong Tian, Xiaoying Wang, Yinmo Yang   +7 more
wiley   +1 more source

Regulatory insights on gene therapies, adeno-associated virus-based gene therapies, cell/tissue-based products, and medical care/practice in cell and gene therapies: Report from the 7th Asia partnership conference - April 25, 2024. [PDF]

Regen Ther
Tsurumaki Y, Kagawa Y, Hayashi S, Mizoguchi H, Miyano M, Fujii M, Shinozaki R, Kellathur SN, Zhang AJ, Suzuki K, Nomura M.   +10 more
europepmc   +1 more source

Tendu leaves refuse as a biosorbent for COD removal from molasses fermentation based bulk drug industry effluent

, 2006
GK Nagda, VS Ghole, A.M. Diwan
openalex   +2 more sources

Australian drug industry gives details of money spent courting doctors [PDF]

, 2008
Bob Burton
openalex   +1 more source

Clinical validation of myOSLchip: A beryllium oxide optically stimulated luminescent dosimeter (OSLD) system in radiotherapy dosimetry

Journal of Applied Clinical Medical Physics, EarlyView.
Abstract In radiation oncology, inter‐fractional dosimetry using optically stimulated luminescent detectors (OSLDs) ensures accurate plan delivery and patient safety. RadPro International GmbH's myOLSchip system, featuring a beryllium oxide (BeO) OSL dosimeter, reader, and eraser, was characterized and calibrated with a Varian Truebeam for in‐vivo ...
Heath Davis, Jeffrey V. Siebers, Krishni Wijesooriya, Matt Mistro   +3 more
wiley   +1 more source

Should the drug industry work with key opinion leaders? No [PDF]

, 2008
Giovanni A. Fava
openalex   +1 more source

Improving dose delivery in non‐coplanar cranial SRS: Stereoscopic x‐ray‐guided mitigation of table walkout errors

Journal of Applied Clinical Medical Physics, EarlyView.
Purpose Linear accelerator (LINAC)‐based single‐isocenter multi‐target (SIMT) treatment has streamlined the cranial stereotactic radiosurgery (SRS) workflow. Though efficient, SIMT delivery adds additional challenges that should be considered, including increased sensitivity to rotational errors for off‐isocenter targets.
Yohan A. Walter, Philip F. Durham, Anne N. Hubbard, William E. Burrell, Hsinshun T. Wu   +4 more
wiley   +1 more source

Debates over orphan drug pricing: a meta-narrative literature review. [PDF]

Orphanet J Rare Dis
Hanchard MS.
europepmc   +1 more source

Implementation of needle‐tracking technology for real‐time transrectal ultrasound‐guided interstitial gynecological HDR brachytherapy: A feasibility study

Journal of Applied Clinical Medical Physics, EarlyView.
Abstract Purpose To investigate the feasibility of adapting a commercial prostate biopsy system for transrectal ultrasound (TRUS)‐guided hybrid gynecological (GYN) high‐dose‐rate (HDR) brachytherapy (BT). Leveraging 3D‐TRUS and MR image fusion, the prototype system aims to improve real‐time needle placement accuracy.
Lindsey H. Bloom, Diandra Ayala‐Peacock, Rajesh Venkataraman, Brett Eckroate, Ryan Sanford, Junzo Chino, Yongbok Kim, Julie Raffi, Oana Craciunescu   +8 more
wiley   +1 more source